An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse model.
Eur J Pharmacol. 2006 Mar 18;534(1-3):233-40. doi: 10.1016/j.ejphar.2006.01.004. Epub 2006 Feb 20.
Eur J Pharmacol. 2006.
PMID: 16487962